Activation of the hypoxia-inducible factor-1 in overloaded temporomandibular joint, and induction of osteoclastogenesis

Biochemical and Biophysical Research Communications

Volumn 393, Issue 4, 2010, Pages 800-805

  Shirakura, Maya ^a   Tanimoto, Keiji ^b   Eguchi, Hidetaka ^c   Miyauchi, Mutsumi ^a   Nakamura, Hideaki ^b,e   Hiyama, Keiko ^b   Tanimoto, Kotaro ^a   Tanaka, Eiji ^a,d   Takata, Takashi ^a   Tanne, Kazuo ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chondrocyte; Hypoxia inducible factor 1 (Hif 1); Osteoarthritis (OA); Osteoprotegerin (Opg); Temporomandibular joint (TMJ)

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL COUNT; CELL CULTURE; CELL DEGENERATION; CELL DIFFERENTIATION; CELL MATURATION; DISEASE MODEL; MANDIBLE CONDYLE; NONHUMAN; OSTEOARTHRITIS; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TEMPOROMANDIBULAR OSTEOARTHRITIS;

ANIMALS; BONE RESORPTION; CARTILAGE, ARTICULAR; CHONDROCYTES; DISEASE MODELS, ANIMAL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; OSTEOARTHRITIS; OSTEOCLASTS; RATS; RATS, WISTAR; TEMPOROMANDIBULAR JOINT DISORDERS;

RATTUS;

EID: 77949485661     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.086     Document Type: Article

References (23)

1. Goldring M.B. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Pract. Res. Clin. Rheumatol. 20 (2006) 1003-1025
2. Aspden R.M. Osteoarthritis: a problem of growth not decay?. Rheumatology 47 (2008) 1452-1460
3. Kuroda S., Tanimoto K., Izawa T., Fujihara S., Koolstra J.H., and Tanaka E. Biomechanical and biomedical characteristics of the mandibular condylar cartilage. Osteoarthritis Cartilage 11 (2009) 1408-1415
4. Tanaka E., Aoyama J., Miyauchi M., Takata T., Hanaoka K., Iwabe T., and Tanne K. Vascular endothelial growth factor plays an important autocrine/paracrine role in the progression of osteoarthritis. Histochem. Cell Biol. 123 (2005) 275-281
5. Forsythe J.A., Jiang B.H., Lyer N.V., Agani F., Leung S.W., Koos R.D., and Semenza G.L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16 (1996) 4604-4613
6. Pufe T., Lemke A., Kurz B., Petersen W., Tillmann B., Grodzinsky A.J., and Mentlein R. Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Am. J. Pathol. 164 (2004) 185-192
7. Niida S., Kaku M., Amano H., Yoshida H., Kataoka H., Nishikawa S., Tanne K., Maeda N., Nishikawa N., and Kodama H. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J. Exp. Med. 190 (1999) 293-298
8. Engsig M.T., Chen Q.J., Vu T.H., Pedersen A.C., Therkidsen B., Lund L.R., Henriksen K., Lenhard T., Foged N.T., Werb Z., and Delaissé J.M. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151 (2000) 879-889
9. Yunokawa M., Tanimoto K., Nakamura H., Nagai N., Kudo Y., Kawamoto T., Kato Y., Hiyama E., Hiyama K., and Nishiyama M. Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas. Oncol. Rep. 17 (2007) 871-878
10. Minkin C., and Yu X.H. Calcitonin receptor expression and its regulation by 1 alpha-25-dihydroxyvitamin D3 during de novo osteoclast formation in organ cultures of fetal mouse metatarsals. Bone Miner. 13 (1991) 191-200
11. Shukunami C., Shigeno C., Atsumi T., Ishizeki K., Suzuki F., and Hiraki Y. Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J. Cell Biol. 133 (1996) 457-468
12. Shukunami C., Ishizeki K., Atsumi T., Ohta Y., Suzuki F., and Hiraki Y. Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J. Bone Miner. Res. 12 (1997) 1174-1188
13. Tanne Y., Tanimoto K., Tanaka N., Ueki M., Lin Y.Y., Ohkuma S., Kamiya T., Tanaka E., and Tanne K. Expression and activity of Runx2 mediated by hyaluronan during chondrocyte differentiation. Arch. Oral Biol. 53 (2008) 478-487
14. Nakamura H., Tanimoto K., Hiyama K., Yunokawa M., Kawamoto T., Kato Y., Yoshiga K., Poellinger L., Hiyama E., and Nishiyama M. Human mismatch repair gene, MLH1, is transcriptionally repressed by the hypoxia-inducible factors, DEC1 and DEC2. Oncogene 27 (2008) 4200-4209
15. Ohnuki Y., Saeki Y., Yamane A., and Yanagisawa K. Quantitative changes in the mRNA for contractile proteins and metabolic enzymes in masseter muscle of bite-opened rats. Arch. Oral Biol. 45 (2000) 1025-1032
16. Stolz M., Gottardi R., Raiteri R., Moit S., Martin I., Imer R., Staufer U., Raducanu A., Duggelin M., Baschong W., Daniels A.U., Friederich N.F., Aszodi A., and Aebi U. Early detection of aging cartilage and osteoarthritis in mice and patient samples using atomic force microscopy. Nat. Nanotechnol. 4 (2009) 186-192
17. Yudoh K., Nakamura H., Masuko-Hongo K., Kato T., and Nishioka K. Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1α in articular chondrocytes: involvement of HIF-1α in the pathogenesis of osteoarthritis. Arthritis Res. Ther. 7 (2005) R904-R914
18. Semenza G.L. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology 24 (2009) 97-106
19. Udagawa N., Takahashi N., Yasuda H., Mizuno A., Itoh K., Ueno Y., Shinki T., Gillespie M.T., Martin T.J., Higashio K., and Suda T. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141 (2000) 3478-3484
20. Huang J.C., Sakata T., Pfleger L.L., Bencsik M., Halloran B.P., Bikle D.D., and Nissenson R.A. PTH differentially regulates expression of RANKL and OPG. J. Bone Miner. Res. 19 (2004) 235-244
21. Karst M., Gorny G., Galvin R.J., and Oursler M.J. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J. Cell Physiol. 200 (2004) 99-106
22. Coetzee M., Haag M., and Kruger M.C. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E2 and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells. J. Nutr. Biochem. 18 (2007) 54-63
23. Tunyogi-Csapo M., Kis-Toth K., Radacs M., Farkas B., Jacobs J.J., Finnegan A., Mikecz K., and Glant T.T. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption. Arthritis Rheum. 58 (2009) 2397-2408